Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
LIGAND PHARMACEUTICALS INC
| Metric | LIGAND PHARMACEUTICALS INC LGNDHealthcare |
|---|---|
| Quality Score | 80 / 100 |
| Revenue (latest) | $268M |
| Net income (latest) | $124M |
| Operating margin | 15.3% |
| Net margin | 46.4% |
| Return on equity | 12.2% |
| Return on assets | 8.0% |
| Return on capital (ROCE) | 2.7% |
| Debt / equity | 0.53× |
| Revenue growth (YoY) | 60.4% |
| Altman Z″ (distress) | 6.75 |
| Accruals / assets | 4.8% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.